Guangzhou Improve Medical Technology Co., Ltd. (hereinafter referred to as" Improve Medical ") was established in 1996, is a laboratory for clinical testing and clinical care to provide relevant technical, products and services, high-tech enterprise, the company main products are the third generation of vacuum blood collection systems, and has successfully developed, production and test marketing microbiological swabs, in vitro diagnostic reagents, the cuff, infusion pumps and other clinical laboratory tests and clinical care areas products.

company's main product vacuum blood collection has about 3,000 kinds of goods regulations, vacuum vessel is the world's most goods regulations, the world's most special inspection special test tube, the world's blood serum collected in serum preparation class supplier of the fastest vacuum blood collection systems and high-end domestic market leader. The third-generation R & D vacuum blood collection system to help medical personnel quick access to qualified human venous blood samples at the same time, can inhibit the blood samples after in vitro variation, and also to achieve the personnel, specimens, equipment and environmental safety of the whole process of protection . At present, Yang Pu medical products and services has covered more than 70 countries and regions worldwide, nearly 2,000 medical institutions to provide products and technical services.

Improve Medical as innovative as the survival and development of the power source. Improve Medical has a professional R & D team, experienced team to undertake the national ministries, provincial, municipal, district-level scientific and technological project planning, research and development associated with the product direction, including basic research in disciplines of basic research and the establishment of full on technology and product development research, and many inside and outside the universities and medical institutions to maintain close co-operation, as of now, the company now has eight non-patented proprietary technology core, 41 patent applications, of which 12 patent applications, 26 utility model patent applications, three design patent applications, thus bringing the company's own R & D results into effective protection of intellectual property together. In addition, to meet the state's 863 plan, in the immune system and blood culture system of innovation has made great progress in the subject, China's biotechnology research to develop a new situation.